Detection of VIM-34, a novel VIM-1 variant identified in the intercontinental ST15 Klebsiella pneumoniae clone

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 1, 2014, Pages 274-275

  Rodrigues, Carla ^a   Novais, Â ngela ^a   Machado, Elisabete ^a,b   Peixe, Luísa ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Carbapenem resistance; Class 1 integron; Esbl; Mbl; Pandemic

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; MEROPENEM; METALLO BETA LACTAMASE; NALIDIXIC ACID; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULFONAMIDE; TIMENTIN; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; VIM 34 PROTEIN;

ACHROMOBACTER XYLOSOXIDANS; AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; CHROMOSOME BAND; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENERAL HOSPITAL; GENETIC VARIABILITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; URINALYSIS;

CARBAPENEM RESISTANCE; CLASS 1 INTEGRON; ESBL; MBL; PANDEMIC;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DNA, BACTERIAL; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 84890342175     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt314     Document Type: Letter

References (11)

1. Cantón R, Akóva M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-31.
2. Samuelsenø, TolemanMA, Hasseltvedt Vet al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect 2011; 17: 1811-6.
3. Sánchez-Romero I, Asensio A, Oteo J et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 2012; 56: 420-7.
4. Tato M, Coque TM, Baquero F et al. Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010; 54: 320-7.
5. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-b-lactamases: a last frontier for b-lactams?. Lancet Infect Dis 2011; 11: 381-93.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.
7. NovaisÂ, Rodrigues C, BranquinhoRet al. Spread of anOmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem resistant Enterobacteriaceae species and clones. Eur J Clin Microbiol Infect Dis 2012; 31: 3057-63.
8. NovaisÂ, ComasI, BaqueroFet al. Evolutionarytrajectoriesofb-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog 2010; 6: e1000735.
9. Damjanova I, Tóth A, Pászti J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M- 15-type b-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'?. J Antimicrob Chemother 2008; 62: 978-85.
10. Poirel L, Benouda A, Hays C et al. Emergence of NDM-1-producing KlebsiellapneumoniaeinMorocco. JAntimicrobChemother 2011;66:2781-3.
11. Novais Â, Baquero F, Machado E et al. International spread and persistence of TEM-24 is caused by the confluence of highly penetrating Enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21. Antimicrob Agents Chemother 2010; 54: 825-34.